Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Diamedica Therapeutics Inc (DMAC)

Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Diamedica Therapeutics Inc 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 USA

www.diamedica.com Employees: 28 P: 763-496-5454

Sector:

Medical

Description:

DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists DM199, a recombinant human tissue kallikrein-1 protein. It operates primarily in the United States and Canada. DiaMedica Therapeutics Inc. is headquartered in Minneapolis, Minnesota.

Key Statistics

Overview:

Market Capitalization, $K 444,737
Enterprise Value, $K 441,707
Shares Outstanding, K 52,077
Float, K 48,275
% Float 92.70%
Short Interest, K 5,302
Short Float 10.18%
Days to Cover 10.71
Short Volume Ratio 0.68
% of Insider Shareholders 7.30%
% of Institutional Shareholders 10.12%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -24,440 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,620 K
EBIT, $ -33,600 K
EBITDA, $ -34,900 K

Growth:

1-Year Return 33.60%
3-Year Return 382.48%
5-Year Return -14.79%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 32.58%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.17 on 11/12/25
Next Earnings Date 03/16/26
Earnings Per Share ttm -0.71
EPS Growth vs. Prev Qtr 5.56%
EPS Growth vs. Prev Year -13.33%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

DMAC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -83.22%
Return-on-Assets % -73.53%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 8.68
Book Value/Share 0.99
Interest Coverage -2.20
60-Month Beta 1.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar